Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Diabetes and a large waist circumference are predictors of liver fat accumulation and fibrosis.
Data from 42,000 people with HIV suggest that income and Medicaid coverage play a role in unintentional weight loss.
Older HIV drugs are in part to blame for the rising rate, but newer medications, like integrase inhibitors, are not.
Management involves lifestyle changes, such as weight loss and exercise.
Weight loss, exercise and a healthy diet are keys to managing type 2 diabetes.
Excess weight, which is often linked to metabolic abnormalities, can contribute to a wide variety of health problems.
The antiretroviral drug class includes bictegravir, dolutegravir, elvitegravir and raltegravir.
These two integrase inhibitors are associated with high blood sugar and diabetes.
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.
Hypertension raises the risk of heart disease and severe COVID-19.
A recent study of noncommunicable disease found mood disorders were linked to metabolic syndrome in particular among people with HIV.
Non-alcoholic fatty liver disease is more common among those with the virus compared with the general population.
A recent study of noncommunicable disease found mood disorders were linked to metabolic syndrome in particular.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.